Sativa Wellness - SATIVA QUALIFIES FOR NEW APEX MARKET SEGMENT
RNS Number : 5819I
Sativa Wellness Group Inc.
15 December 2020
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Sativa Wellness Group Inc.
("Sativa" or "Sativa Wellness" the "Company" or the "Group")

15 December 2020 

 

SATIVA QUALIFIES FOR NEW APEX MARKET SEGMENT

 

Sativa Wellness (AQSE and CSE: SWEL) notes today's announcement by the Aquis Stock Exchange PLC, that the two new segments of the market have come into force. Please see Aquis Stock Exchange link for the full announcement.

 

Sativa Wellness has been notified by AQSE that it qualifies for the "Apex" segment of the AQSE Growth Market. In order to be eligible for admission to Apex, Sativa has succeeded in meeting, amongst other things, the following eligibility criteria:

·   A minimum market capitalisation of £10 million

·   At least 25% shares in public hands

·   At least 2 market makers

·   A minimum 2 years' trading history

·   Adopted a recognised governance code

 

In meeting the above criteria, the Company expects that there will be more retail and institutional interest, leading to higher trading volumes, and an enhanced ability to use its APEX segment public market status to raise money.

 

Henry Lees-Buckley, CEO of the Sativa Wellness Group Inc. stated "the status of the Apex segment is clearly designed for more established companies that have experienced boards and corporate governance standards. We welcome this segmentation from the Aquis Stock Exchange, and believe that the Apex segment is better placed to support our growth ambitions".    

The Directors of the Company accept responsibility for the contents of this announcement.

On behalf of the Board of Directors,

 

 

Henry Lees-Buckley 

Chief Executive Officer

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

enquiries@sativawellnessgroup.com

www.sativawellnessgroup.com

Joseph Colliver

Chief Financial Officer

Sativa Wellness Group Inc.

+44 (0) 20 7971 1255

enquiries@sativawellnessgroup.com

www.sativawellnessgroup.com

 

 

 

Jason Dussault

Investor Relations and Communications

Sativa Wellness Group Inc. jason@sativawellnessgroup.com www.sativawellnessgroup.com

AQSE Growth Market Corporate Adviser

Peterhouse Capital Limited

Guy Miller/Allie Feuerlein

+ 44 (0) 20 7220 9795 

 

 

This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXTIBTTMTTBBLM ]]>